Regenerative Medicine Assets Limited (formerly Intercytex Group plc) today announces that Regenerative Solutions Limited has exercised its option to acquire the entire share capital of Intercytex Limited for a nominal sum. The option was granted to Regenerative Solutions Limited as part of the sale of Vavelta announced on 19 April 2010.
Regenerative Medicine Assets Limited has now completed all transactions it anticipated in the circular to shareholders dated 7 December 2009. However, one of these transactions included a contingent milestone payment which has yet to be received. The Company continues to work to ensure receipt of this final contingent payment.
|< Prev||Next >|